Literature DB >> 26785041

Whole-Brain CT Perfusion to Quantify Acute Ischemic Penumbra and Core.

Longting Lin1, Andrew Bivard1, Venkatesh Krishnamurthy1, Christopher R Levi1, Mark W Parsons1.   

Abstract

Purpose To validate the use of perfusion computed tomography (CT) with whole-brain coverage to measure the ischemic penumbra and core and to compare its performance to that of limited-coverage perfusion CT. Materials and Methods Institutional ethics committee approval and informed consent were obtained. Patients (n = 296) who underwent 320-detector CT perfusion within 6 hours of the onset of ischemic stroke were studied. First, the ischemic volume at CT perfusion was compared with the penumbra and core reference values at magnetic resonance (MR) imaging to derive CT perfusion penumbra and core thresholds. Second, the thresholds were tested in a different group of patients to predict the final infarction at diffusion-weighted imaging 24 hours after CT perfusion. Third, the change in ischemic volume delineated by the optimal penumbra and core threshold was determined as the brain coverage was gradually reduced from 160 mm to 20 mm. The Wilcoxon signed-rank test, concordance correlation coefficient (CCC), and analysis of variance were used for the first, second, and third steps, respectively. Results CT perfusion at penumbra and core thresholds resulted in the least volumetric difference from MR imaging reference values with delay times greater than 3 seconds and delay-corrected cerebral blood flow of less than 30% (P = .34 and .33, respectively). When the thresholds were applied to the new group of patients, prediction of the final infarction was allowed with delay times greater than 3 seconds in patients with no recanalization of the occluded artery (CCC, 0.96 [95% confidence interval: 0.92, 0.98]) and with delay-corrected cerebral blood flow less than 30% in patients with complete recanalization (CCC, 0.91 [95% confidence interval: 0.83, 0.95]). However, the ischemic volume with a delay time greater than 3 seconds was underestimated when the brain coverage was reduced to 80 mm (P = .04) and the core volume measured as cerebral blood flow less than 30% was underestimated when brain coverage was 40 mm or less (P < .0001). Conclusion Correct threshold setting and whole-brain coverage CT perfusion allowed differentiation of the penumbra from the ischemic core in patients with acute ischemic stroke. (©) RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2016        PMID: 26785041     DOI: 10.1148/radiol.2015150319

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  A "one-stop-shop" 4D CTA protocol using 320-row CT for advanced imaging in acute ischemic stroke: a technical note.

Authors:  Julien Ognard; Brieg Dissaux; Karim Haioun; Michel Nonent; Jean-Christophe Gentric; Douraïed Ben Salem
Journal:  Eur Radiol       Date:  2019-02-15       Impact factor: 5.315

2.  Perfusion CT for prediction of hemorrhagic transformation in acute ischemic stroke: a systematic review and meta-analysis.

Authors:  Chong Hyun Suh; Seung Chai Jung; Se Jin Cho; Donghyun Kim; Jung Bin Lee; Dong-Cheol Woo; Woo Yong Oh; Jong Gu Lee; Kyung Won Kim
Journal:  Eur Radiol       Date:  2019-01-07       Impact factor: 5.315

3.  Quantifying reperfusion of the ischemic region on whole-brain computed tomography perfusion.

Authors:  Longting Lin; Xin Cheng; Andrew Bivard; Christopher R Levi; Qiang Dong; Mark W Parsons
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  The accuracy of ischemic core perfusion thresholds varies according to time to recanalization in stroke patients treated with mechanical thrombectomy: A comprehensive whole-brain computed tomography perfusion study.

Authors:  Carlos Laredo; Arturo Renú; Raúl Tudela; Antonio Lopez-Rueda; Xabier Urra; Laura Llull; Napoleón G Macías; Salvatore Rudilosso; Víctor Obach; Sergio Amaro; Ángel Chamorro
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-17       Impact factor: 6.200

5.  Leukoaraiosis May Confound the Interpretation of CT Perfusion in Patients Treated with Mechanical Thrombectomy for Acute Ischemic Stroke.

Authors:  S Rudilosso; C Laredo; C Vivancos; X Urra; L Llull; A Renú; V Obach; Y Zhao; J L Moreno; A Lopez-Rueda; S Amaro; Á Chamorro
Journal:  AJNR Am J Neuroradiol       Date:  2019-07-25       Impact factor: 3.825

6.  Ischemic Lesion Growth in Patients with a Persistent Target Mismatch After Large Vessel Occlusion.

Authors:  Shinya Tomari; Thomas Lillicrap; Carlos Garcia-Esperon; Yumi Tomari Kashida; Andrew Bivard; Longting Lin; Christopher R Levi; Neil J Spratt
Journal:  Clin Neuroradiol       Date:  2022-07-05       Impact factor: 3.649

Review 7.  Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy.

Authors:  Lucie Chalet; Timothé Boutelier; Thomas Christen; Dorian Raguenes; Justine Debatisse; Omer Faruk Eker; Guillaume Becker; Norbert Nighoghossian; Tae-Hee Cho; Emmanuelle Canet-Soulas; Laura Mechtouff
Journal:  Front Cardiovasc Med       Date:  2022-03-09

Review 8.  Imaging selection for reperfusion therapy in acute ischemic stroke beyond the conventional time window.

Authors:  Lauranne Scheldeman; Anke Wouters; Robin Lemmens
Journal:  J Neurol       Date:  2021-10-31       Impact factor: 4.849

Review 9.  Preprocedural Imaging : A Review of Different Radiological Factors Affecting the Outcome of Thrombectomy.

Authors:  Mingxue Jing; Joshua Y P Yeo; Staffan Holmin; Tommy Andersson; Fabian Arnberg; Paul Bhogal; Cunli Yang; Anil Gopinathan; Tian Ming Tu; Benjamin Yong Qiang Tan; Ching Hui Sia; Hock Luen Teoh; Prakash R Paliwal; Bernard P L Chan; Vijay Sharma; Leonard L L Yeo
Journal:  Clin Neuroradiol       Date:  2021-10-28       Impact factor: 3.649

Review 10.  Evolution of the stroke paradigm: A review of delayed recanalization.

Authors:  Richard Camara; Nathanael Matei; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2020-12-16       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.